FDA panel weighs moving opioid antidote over the counter
FDA panel weighs moving opioid antidote over the counter
1 year ago
316
U.S. wellness advisers connected Wednesday were weighing whether the overdose-reversal cause naloxone should beryllium made disposable arsenic an over-the-counter medicine to assistance combat the nationalist opioid crisis.